Apr 012024
Drug Name |
Active Ingredient(s) |
Approval Date |
FDA-Approved Use on Approval Date |
Press Release |
Drug Trials Snapshot |
| Voydeya | danicopan | 3/29/2024 | To treat extravascular hemolysis with paroxysmal nocturnal hemoglobinuria | Drug Trials Snapshot | |
| Vafseo | vadadustat | 3/27/2024 | To treat anemia due to chronic kidney disease | ||
| Winrevair | sotatercept-csrk | 3/26/2024 | To treat pulmonary arterial hypertension | Drug Trials Snapshot | |
| Duvyzat | givinostat | 3/21/2024 | To treat Duchenne muscular dystrophy in individuals aged 6 years and older | Press Release | Drug Trials Snapshot |
| Tryvio | aprocitentan | 3/19/2024 | To treat hypertension | Drug Trials Snapshot | |
| Rezdiffra | resmetirom | 3/14/2024 | To treat noncirrhotic non-alcoholic steatohepatitis with moderate to advanced liver scarring | Press Release | |
| Tevimbra | tislelizumab-jsgr | 3/13/2024 | To treat unresectable or metastatic esophageal squamous cell carcinoma | Drug Trials Snapshot |
Sorry, the comment form is closed at this time.